Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Diabetic patients' stem cells make vascular grafts more prone to clots, but new methods may improve grafts.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The treatment improved facial structure and corrected bite issues in patients.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Powered exoskeleton training improves body perception and quality of life in spinal cord injury patients.

Breast cancer patients need strong psychological support to improve their quality of life.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Lifestyle changes improve weight, waist size, menstrual regularity, and acne in teens with PCOS.

Estheticians in dermatology improve patient satisfaction and loyalty with proper training and planning.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

A specific gene variant may increase the risk of developing Alopecia Areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Misdiagnosis of hair and scalp disorders is common in patients with skin of color, highlighting the need for better training and evaluation.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A new teledermatology system improved access and reduced wait times for skin care.